PNEUMOCOCCAL DISEASE

This study tested the safety and immune response of two pneumococcal vaccines (20vPnC and 13vPnC) in Chinese adults aged 50 and older who had never received a pneumococcal vaccine before. Four hundred participants received one dose of either vaccine and were monitored for six mon…

This study tested the safety and immune response of a new pneumococcal vaccine in healthy toddlers aged 12 to 15 months. The trial involved 225 children who received either one or two doses of the vaccine over 6-8 months. Researchers monitored for side effects and measured antibo…

This study tested a new vaccine designed to protect infants against 20 strains of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. It compared the new vaccine to an older, licensed vaccine in about 540 healthy babies in India and Taiwan. Re…

This study tested a new vaccine called V116 designed to protect against pneumococcal disease, which can cause pneumonia and other serious infections. It was compared directly to an existing vaccine (PPSV23) in over 1,400 adults aged 50 and older who had never received a pneumococ…

This study tested a new vaccine called V116 designed to prevent pneumococcal disease, a serious type of bacterial pneumonia, in adults living with HIV. It involved 313 participants and compared the new vaccine's safety and immune response to an existing vaccine combination. The g…